Cargando…
Intramyometrial vasopressin as a haemostatic agent: Is it really safe?
Autores principales: | Muthukumar, M, Mathews, L, Vasantha, NS, Anoop, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322105/ https://www.ncbi.nlm.nih.gov/pubmed/25684816 http://dx.doi.org/10.4103/0019-5049.149456 |
Ejemplares similares
-
Intramyometrial vasopressin: Anesthesiologists’ nightmare
por: Jayaraman, Lakshmi, et al.
Publicado: (2013) -
Intramyometrial vasopressin: A fear for anesthetist?
por: Kabade, Savitri D., et al.
Publicado: (2017) -
Intramyometrial injection of vasopressin resulting in severe bradycardia during myomectomy
por: Song, Li-Ping, et al.
Publicado: (2021) -
Bradycardia and severe vasospasm caused by intramyometrial injection of vasopressin during myomectomy
por: Butala, Bina P., et al.
Publicado: (2014) -
Risk of vasopressin use: a case of acute pulmonary oedema, post intramyometrial infiltration of vasopressin in laparoscopic myomectomy
por: Barcroft, Jennifer Frances, et al.
Publicado: (2019)